Previous close | 142.31 |
Open | 140.12 |
Bid | 138.50 x 900 |
Ask | 150.00 x 800 |
Day's range | 137.64 - 142.85 |
52-week range | 112.07 - 305.21 |
Volume | |
Avg. volume | 1,047,013 |
Market cap | 7.852B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | 36.54 |
EPS (TTM) | 3.87 |
Earnings date | 25 July 2022 - 29 July 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 23 Nov 2012 |
1y target est | 156.25 |
Change Healthcare (CHNG) continues to benefit from strategic deals. However, intense competition remains a woe.
Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.
Medtronic's (MDT) Cardiovascular business is expected to have gained share in both high and low power devices in Q4.